Earnings Call · Q2 FY2023·2023-08-12

Q2 23EPS +13.04%·Rev n/aQ1 23EPS +4.17%·Rev n/aQ4 22EPS +42.86%·Rev n/aQ3 22EPS +24.14%·Rev n/a⚠ consensus missing

TREACE MEDICAL CONCEPTS, INC. TMCI

Julie Dewey — Chief Communications and IR Officer

John Treace — Chief Executive Officer

Mark Hair — Chief Financial Officer

−2.9%1d on move date−2.5% vs SPY3d−17.1%5d−16.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TMCI calls or request research access.

More TMCI calls Browse calls Request research access